Iranian Journal of Pharmaceutical Research

1. Potential anti-tumor activity of kefir-induced juglone and resveratrol fractions against Ehrlich ascites carcinoma-bearing BALB/c mice

Volume 19, Issue 3, Summer 2020, Pages 358-369

Erhan Bozkurt; Emre Atay; Gökhan Pektaş; Ayşe Ertekin; Ayhan Vurmaz; Omer Adil Korkmaz; Gokhan Sadi; Esra Aslan; Oğuz Han Koca; Mehmet Bilgehan Pektaş

2. Developing a CoMSIA model for inhibition of COX-2 by resveratrol derivatives

Volume 15, Issue 3, Summer 2016, Pages 459-469

Jamal Shamsara; Ahamad Shahir-Sadr

3. Effects of resveratrol on crosstalk between canonical β-catenin/Wnt and FOXO pathways in coronary artery disease patients with metabolic syndrome: a case control study

Volume 15, Issue 3, Summer 2016, Pages 547-559

Mehrnoosh Shanaki Bavarsad; Taghi Golmohammadi; Arash Hossein-nezhad; Reza Meshkani; Maani Beigy; Mahmoud Shirzad; Parvin Pasalar

4. Resveratrol Provides Cardioprotection after Ischemia/reperfusion Injury via Modulation of Antioxidant Enzyme Activities

Volume 12, Issue 4, Autumn 2013, Pages 867-875

Meherzia Mokni; Sonia Hamlaoui; Ines Karkouch; Mohamed Amri; Lamjed Marzouki; Ferid Limam; Ezzedine Aouani

1. Potential anti-tumor activity of kefir-induced juglone and resveratrol fractions against Ehrlich ascites carcinoma-bearing BALB/c mice

2. Developing a CoMSIA model for inhibition of COX-2 by resveratrol derivatives

3. Effects of resveratrol on crosstalk between canonical β-catenin/Wnt and FOXO pathways in coronary artery disease patients with metabolic syndrome: a case control study

4. Resveratrol Provides Cardioprotection after Ischemia/reperfusion Injury via Modulation of Antioxidant Enzyme Activities

Journal Archive